The effect of catheter ablation for ventricular arrhythmias originating from the left ventricular papillary muscles

Joshua Sink1, Alexander Turin2, Joseph Cytron2

  • 1Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.

Abstract

Insights

Radiofrequency ablation of ventricular arrhythmias from papillary muscles did not significantly worsen mitral regurgitation. This study found no significant increase in mitral regurgitation severity after papillary muscle ablation for ventricular arrhythmias.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Surgery

Background:

  • Ventricular arrhythmias (VA) originating from left ventricular (LV) papillary muscles (PM) pose a risk of mitral regurgitation (MR) due to potential damage to the mitral valve apparatus.
  • Radiofrequency (RF) ablation is a common treatment for VA, but its effect on MR when targeting PM is not fully understood.

Purpose of the Study:

  • To evaluate the impact of RF ablation of PM on the severity of MR.
  • To compare MR changes in patients undergoing PM ablation versus non-PM ablation for VA.

Main Methods:

  • Retrospective analysis of patients undergoing PM ablation for VA, compared to a control group undergoing ablation at non-PM sites.
  • Transthoracic echocardiograms were used to assess MR severity (graded 0-3) pre- and postablation in both groups.

Main Results:

  • 45 patients in the PM group and 49 in the non-PM group were analyzed. PM ablation involved longer RF times (22.3 vs. 13.3 min).
  • No statistically significant change in MR severity was observed within the PM group postablation (p=0.46).
  • Logistic regression indicated no significant increase in the odds of worsening MR in the PM group compared to the non-PM group (OR=0.19, p=0.29).

Conclusions:

  • RF ablation of VA originating from PM, guided by intracardiac echocardiography, does not lead to clinically significant worsening of MR.
  • The procedure appears safe concerning mitral valve function in the context of MR severity.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
120
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
111
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
64
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
121
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
70
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
80